| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions relates to pharmaceutical composition, which contains parathyroid hormone (PTH), methionine, at least one SAS poloxamer and physiologically acceptable buffer preparation, which can be applied in animals and people, as well as to method of obtaining said composition and application. n EFFECT: group of inventions ensures composition solution stability and prolonged storage term. n 19 cl, 11 ex, 22 tbl, 3 dwg |